Publication | Closed Access

Safety and immunogenicity of adjuvanted inactivated split-virion and whole-virion influenza A (H5N1) vaccines in children: A phase I–II randomized trial

VaccinationVaccine SafetyVaccine DevelopmentWhole-virion Influenza AImmunologyImmunodominancePhase I–iiInfluenza VaccineFlu VaccinationMedicineVaccine ResearchAdjuvanted Inactivated Split-virionInfluenza Vaccines